Tag: evh

Evolent Health (EVH) carries a Strong Sell rating because its 25.4% FCF yield and strong cash generation do not offset 14.0x net debt/EBITDA and negative operating margin. The balance sheet remains the central risk, even with revenue growth and a cheap EV/revenue multiple.

Read note